5 years ago

Analysis of Survival for Patients with Chronic Kidney Disease Primarily Related to Renal Cancer Surgery

Steven C. Campbell, Ithaar H. Derweesh, Elvis Caraballo Antonio, Wen Dong, Sevag Demirjian, Jitao Wu, Chalairat Suk-Ouichai, Jianbo Li, Brian R. Lane
Objectives To evaluate predictors of long-term survival for patients with chronic kidney disease primarily due to surgery (CKD-S). Patients with CKD-S have generally good survival that approximates patients who do not have CKD even after renal cancer surgery (RCS), yet there may be heterogeneity within this cohort. Patients and Methods From 1997-2008, 4,246 patients underwent RCS at our center. Median follow-up was 9.4 years (IQR=7.3-11.0). New baseline GFR was defined as highest GFR between nadir and 6 weeks after surgery. We retrospectively evaluated 3 cohorts: no-CKD (new baseline GFR≥60ml/min/1.73m2); CKD-S (new baseline GFR<60ml/min/1.73m2 but preoperative GFR≥60ml/min/1.73m2); and CKD-M/S (preoperative and new baseline GFR both <60ml/min/1.73m2). Analysis focused primarily on non-renal cancer-related survival (NRCRS) for the CKD-S cohort. Kaplan-Meier assessed longitudinal impact of new baseline GFR (45-60ml/min/1.73m2 versus <45ml/min/1.73m2) and Cox regression evaluated relative impact of preoperative GFR, new baseline GFR, and relevant demographics/comorbidities. Results Of 4,246 patients who underwent RCS, 931 had CKD-S and 1,113 had CKD-M/S, while 2,202 had no-CKD even after surgery. Partial/radical nephrectomy (PN/RN) were performed in 54%/46% of patients, respectively. For CKD-S, 641 patients had new baseline GFR 45-60ml/min/1.73m2 and 290 had new baseline GFR<45ml/min/1.73m2. Kaplan-Meier demonstrated significantly reduced NRCRS for CKD-S with GFR<45ml/min/1.73m2 compared to no-CKD or CKD-S with GFR 45-60ml/min/1.73m2 (both p≤0.004), and competing risk analysis confirmed this (p<0.001). Age/gender/heart disease, and new baseline GFR all associated independently with NRCRS for patients with CKD-S (all p≤0.02). Conclusion Our data suggest that CKD-S is heterogeneous, and patients with reduced new baseline GFR have compromised survival, particularly if <45ml/min/1.73m2. Our findings may have implications regarding choice of PN/RN in patients at risk for developing CKD-S. This article is protected by copyright. All rights reserved.

Publisher URL: http://onlinelibrary.wiley.com/resolve/doi

DOI: 10.1111/bju.13994

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.